Galena Biopharma, Inc. 4
4 · Galena Biopharma, Inc. · Filed Dec 22, 2015
Insider Transaction Report
Form 4
SCHWARTZ MARK W.
EVP Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2015-12-18+1,250,000→ 1,250,000 totalExercise: $1.50Exp: 2025-12-18→ Common Stock (1,250,000 underlying)
Footnotes (2)
- [F1]Granted pursuant to the Issuer's Amended and Restated 2007 Incentive Plan.
- [F2]The stock option will vest in 16 equal, quarterly installments over 4 years, beginning 3 months from the date of grant, so long as the Reporting Person remains in the company's continuous employ of the Issuer through the vesting period.